AbbVie Inc., US00287Y1091

AbbVie stock gains 0.3 percent ahead of the open

Published on 09/23/2026 at 06:34 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

At the close on September 22, 2026, AbbVie stock reached USD 265.21 after trading between USD 263.10 and USD 266.74. The shares gained 0.3 percent in the New York session.

Fotorealistisches Pharma-Forschungslabor mit Petrischalen und Wissenschaftlern in Schutzkleidung
AbbVie Inc. US00287Y1091 fotorealistisches Pharma Forschungslabor mit Petrischalen Wissenschaftlern Immunologie Onkologie Biopharma, Illustration mit AI erstellt.

AbbVie stock closed at USD 265.21 on the NYSE on September 22, 2026, gaining 0.3 percent. The session high was USD 266.74 and the opening price was USD 263.10, according to the dated market report.

September 22, 2026 in numbers

AbbVie Inc. (ISIN US00287Y1091, NYSE: ABBV) traded at USD 265.21 at the close after reaching USD 266.74. The session range from USD 263.10 to USD 266.74 covered USD 3.64. Trading volume was 2.8 million shares, compared with average volume of 6.2 million shares.

The S&P 500 closed at 7,764.64 on September 22, 2026, down 0.06 percent, while AbbVie gained 0.3 percent. That put the stock 0.36 percentage points ahead of the benchmark during the session. Finanzen reported the closing move and daily high.

Today before the open

AbbVie stock enters the September 23, 2026 session after a higher prior close. MarketBeat highlighted European Commission approval of RINVOQ for children with active polyarticular juvenile idiopathic arthritis, providing a company-specific news item for the session.

Disclaimer...

en | US00287Y1091 | ABBVIE INC. | boerse | 70162487 | bgmi